Abstract:Objective This study aimed to examine the clinical distinctions among patients diagnosed with autoimmune encephalitis (AE) based on the presence or absence of cerebrospinal fluid (CSF) oligoclonal bands (OCBs). Additionally, it sought to explore the relationship between OCBs and the severity and prognosis of autoimmune encephalitis. Methods A retrospective analysis was conducted on 94 patients diagnosed with AE at the People’s Hospital of Zhengzhou University between October 2016 and June 2022. The patients were divided into OCB-positive and OCB-negative groups based on CSF-OCBs. Patient severity at admission was assessed utilizing the Clinical Assessment Scale for Autoimmune Encephalitis (CASE) and the modified Rankin scale (mRS). Additionally, some oligoclonal-positive patients underwent dynamic longitudinal analysis of cerebrospinal fluid test indices. The mRS score was ultimately employed to evaluate patients’ short-term prognosis (6 months) and long-term prognosis (at least 12 months) following immunotherapy. Results Of the 94 patients, 34 (36.2%) belonged to the OCB-positive group, while 60 (63.8%) belonged to the OCB-negative group. The group with anti-n-methyl-d-aspartate receptor (anti-NMDAR) encephalitis exhibited the highest rate of oligoclonal positivity at 27 (49.1%), followed by anti-aminobutyric acid B receptor (GABABR) encephalitis with 4 cases (30.8%), anti-contactin-associated protein-like 2 (CASPR2) encephalitis with 2 cases (20%), and anti-leucine-rich glioma inactivating protein 1 (LGI1) encephalitis with 1 case (6.25%). No statistically significant differences were found between the two groups regarding gender, age, prodromal symptoms, psychiatric disorders, seizures, language disorders, motor dysfunction, cognitive dysfunction, tumor incidence, and magnetic resonance imaging (MRI) abnormalities ( p > 0.05). The OCB-positive group exhibited higher rates of autonomic dysfunction, intensive care unit (ICU) admission, CSF leukocytes, and IgG index compared to the OCB-negative group ( p < 0.05). Additionally, the OCB-positive group had significantly higher median CASE and mRS scores prior to immunotherapy than the OCB-negative group ( p < 0.001 and p < 0.001). Furthermore, in both short-term follow-up and long-term follow-up, the OCB-positive group had a significantly lower proportion of patients with a favorable prognosis compared to the OCB-negative group (50% vs. 71.7, 61.8% vs. 83.3%; p = 0.036, p = 0.002). Conclusion Autonomic dysfunction, ICU admission, leukocytes in the cerebrospinal fluid, and elevated IgG index are more commonly observed in OCB-positive patients. OCB-positivity has also been linked to the severity and prognosis of AE, making it a potential biomarker. Initial OCB testing aids clinicians in identifying potentially critically ill patients early and monitoring disease progression, thereby optimizing clinical treatment decisions.

The clinical significance of cerebrospinal fluid oligoclonal bands for multiple sclerosis

Analysis of oligocional band, IgG index and IgG synthesis rate in patients with multiple sclerosis

Clinical Significance of Oligoclonal Bands and IgG Index for Multiple Sclerosis

A study of cerebral spinal fluid oligoclonal bands in neurological diseases.

Cerebrospinal Fluid Oligoclonal Bands in Chinese Patients with Multiple Sclerosis: the Prevalence and Its Association with Clinical Features

Comparison of Multiple Sclerosis Patients with and Without Oligoclonal IgG Bands in South China

Significance of oligoclonal bands,myelin basic protein antibody and myelin oligodendrocyte glycoprotein anti-body in diagnosis of inflammatory central nervous system demyelinating diseases

Diagnostic value of combined detection of cerebrospinal fluid oligoclonal bands and IgG index in central nervous system diseases

IgG Index Revisited: Diagnostic Utility and Prognostic Value in Multiple Sclerosis

Characteristics of cerebrospinal fluid oligoclonal band in anti-myelin oligodendrocyte glycoprotein (MOG) antibody associated disease

Comparing clinical features, severity and prognosis of autoimmune encephalitis and with and without oligoclonal bands

Significance of oligoclonal bands and aquaporin-4 antibody in diagnosis of multiple sclerosis

IgG index for multiple sclerosis diagnosis: old test do the trick

The Role Of Oligoclonal Band Count And Igg Index In Treatment Response And Disease Activity In Multiple Sclerosis

Advanced MRI Features in Relapsing Multiple Sclerosis Patients with and Without CSF Oligoclonal IgG Bands

Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients.

[The combined application of oligoclonal bands in cerebrospinal fluid and IgG intrathecal synthesis indicators and biochemical markers in the diagnosis of multiple sclerosis]

A Comparison of IgG Index and Oligoclonal Band in the Cerebrospinal Fluid for Differentiating between RRMS and NMOSD

CSF oligoclonal IgG bands are not associated with ALS progression and prognosis

Matched oligoclonal bands: Diagnostic utility and clinical characteristics

Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement